News

MEDIA

Fludarabine labelled with Fluor 18: a new radiotracer for onco-hematology

Fludarabine labelled with Fluor 18: a new radiotracer for onco-hematology

June 20, 2019 News

Zionexa, a radiopharmaceutical company specialized in the development and commercialization of innovative molecular imaging companion diagnostics (CDx) for targeted therapies in oncology, [...]

What has been discussed at #ASCO19 session “Meet the professors : Are we ready for prime time in Molecular Imaging in Breast Cancer” ?

What has been discussed at #ASCO19 session “Meet the professors : Are we ready for prime time in Molecular Imaging in Breast Cancer” ?

June 11, 2019 News

Read our CEO US Peter Webner’s opinion on the future of Molecular Imaging published in the June issue of DOTmed news !

Read our CEO US Peter Webner’s opinion on the future of Molecular Imaging published in the June issue of DOTmed news !

June 7, 2019 News

Jean-Bernard Deloye, Head of Market Access, becomes part of Leem’s board, the French industry association for pharmaceutical companies

Jean-Bernard Deloye, Head of Market Access, becomes part of Leem’s board, the French industry association for pharmaceutical companies

May 29, 2019 News

Artur Shchukin joins Zionexa as RA/QA Manager

Artur Shchukin joins Zionexa as RA/QA Manager

May 23, 2019 News

Zionexa announces FDA acceptance of New Drug Application (NDA) for FES (Fluoroestradiol F18), a biomarker for targeted imaging in Metastatic Breast Cancer (MBC)

Zionexa announces FDA acceptance of New Drug Application (NDA) for FES (Fluoroestradiol F18), a biomarker for targeted imaging in Metastatic Breast Cancer (MBC)

May 21, 2019 News